What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Giovanni Monteleone mainly focuses on Immunology, Cytokine, Inflammation, Interleukin and Immune system.
His Immunology study integrates concerns from other disciplines, such as Lamina propria, Inflammatory bowel disease and Ulcerative colitis.
His research in Ulcerative colitis intersects with topics in Crohn's disease, Colorectal cancer and Gastroenterology.
His Cytokine research is multidisciplinary, relying on both Cancer research, Intestinal mucosa, T cell, Interleukin 21 and Molecular biology.
His Interleukin 21 research integrates issues from IL-2 receptor and FOXP3.
His work carried out in the field of Inflammation brings together such families of science as Helicobacter pylori, Gastric mucosa, Transforming growth factor, Experimental colitis and Signalling.
His most cited work include:
- Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 (1031 citations)
- Immunity, Inflammation, and Allergy in the Gut (827 citations)
- Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells (521 citations)
What are the main themes of his work throughout his whole career to date?
Giovanni Monteleone spends much of his time researching Immunology, Cytokine, Immune system, Internal medicine and Inflammatory bowel disease.
His studies deal with areas such as Disease and Ulcerative colitis as well as Immunology.
The concepts of his Cytokine study are interwoven with issues in Cancer research, Intestinal mucosa, Gene knockdown, Lamina propria and Interleukin 21.
His Interleukin 21 research incorporates themes from IL-2 receptor and Cell biology.
His study in Immune system is interdisciplinary in nature, drawing from both Proinflammatory cytokine, Peripheral blood mononuclear cell, Pathogenesis and Antigen.
His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Oncology.
He most often published in these fields:
- Immunology (51.39%)
- Cytokine (24.56%)
- Immune system (23.54%)
What were the highlights of his more recent work (between 2018-2021)?
- Ulcerative colitis (19.75%)
- Crohn's disease (16.71%)
- Internal medicine (22.28%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Ulcerative colitis, Crohn's disease, Internal medicine, Inflammatory bowel disease and Gastroenterology.
His Ulcerative colitis study incorporates themes from Tumor necrosis factor alpha, Colitis, Cytokine, Immune system and Immunology.
His work in Tumor necrosis factor alpha addresses subjects such as Cancer research, which are connected to disciplines such as Cell culture.
His study on Cytokine also encompasses disciplines like
- Gene knockdown that connect with fields like Blot and Molecular biology,
- Inflammation which intersects with area such as Peripheral blood mononuclear cell.
His work in the fields of Dysbiosis overlaps with other areas such as Severe acute respiratory syndrome coronavirus 2.
His Inflammatory bowel disease research includes themes of Transforming growth factor, Clinical trial and Single-nucleotide polymorphism.
Between 2018 and 2021, his most popular works were:
- Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? (80 citations)
- Preventing COVID-19-induced pneumonia with anticytokine therapy (48 citations)
- Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease. (45 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
The scientist’s investigation covers issues in Inflammatory bowel disease, Ulcerative colitis, Immunology, Immune system and Cytokine.
His Ulcerative colitis study combines topics in areas such as Tumor necrosis factor alpha, Infliximab, Colitis, Crohn's disease and Oligonucleotide.
His work focuses on many connections between Colitis and other disciplines, such as Inflammation, that overlap with his field of interest in Extracellular.
His study in Immunology focuses on Dysbiosis in particular.
Giovanni Monteleone interconnects Proinflammatory cytokine and Ustekinumab in the investigation of issues within Immune system.
Giovanni Monteleone has included themes like Receptor, Cancer research, Gene knockdown and Blot in his Cytokine study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
